Presentation Information
[1-MO11-02]Pharmacological profiling of 64Cu/225Ac-PD-29875 in pancreatic and gastric cancer models
Kentaro Suzuki1, Shota Tsuchida2, Yoshihide Mizukoshi2, Shintaro Kato2, Miho Satake1, Yuki Sato1, Naoki Kanazawa1, Satoshi Matsushima1, Patrick C. Reid2, Masato Murakami1,2, Hidetomo Kitamura2 (1.PDRadiopharma Inc., Chiba, Japan, 2.PeptiDream Inc., Kanagawa, Japan)